Sunday, January 29, 2023

Fw: Ref.: (LML) Children affected by leprosy remain invisible, forgotten, and dehumanised


 

 
Leprosy Mailing List – January 29 ,  2023

 

Ref.:  (LML) Children affected by leprosy remain invisible, forgotten, and dehumanised

From:  Alice Cruz, Quito, Ecuador

 

 

Dear Colleagues,

 

Kindly find herewith my last public statement as SR on World Leprosy Day.

As you can see, this statement was endorsed by the Committee on the Rights of the Child and the UNICEF, a great sign of progress with regard to the mainstreaming of Hansen's disease in the overall UN system.

 

Kind regards,

Alice

 

Note Editor: On January 29, 2023, the last Sunday of January, we ask special attention for a World Free of Leprosy, and we call it the World Leprosy Day

 

Children affected by leprosy remain invisible, forgotten, and dehumanised: UN expert

GENEVA (26 January 2023) Children and teenagers affected by leprosy (also known as Hansen's disease) remain hidden, invisible, forgotten and dehumanised, a UN expert said today. Ahead of World Leprosy Day, the Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members, Alice Cruz, issued the following statement:

 

"Leprosy is mostly diagnosed in children aged between 10 and 14 years due to its long incubation period following exposure. Cases among younger children have been observed and, more rarely, cases in infants have also been reported.

 

Since the creation of my mandate in 2017, I have received numerous reports of children affected by leprosy being expelled from schools, separated from other students, rejected by their peers, bullied, verbally and physically abused by family members, neighbours, and schoolteachers. Due to a lack of access to medical care and stigmatisation, informal segregation in "leprosy colonies" still happens in some cases, even if it is no longer implemented as State policy.

 

I received considerable testimonies about persons diagnosed with leprosy during their childhood and who attempted to commit suicide as adults. Stigmatisation has long-lasting impacts over an entire lifetime. Girls affected by leprosy are especially vulnerable to various forms of discrimination and violence.

 

Detection of leprosy cases was significantly impacted by the Covid-19 pandemic when the global detection rate for new child cases dropped from 7.9 to 4.5 per million child population. This is alarming because children affected by leprosy are a strong indicator of the extent of ongoing transmission. For leprosy, under-detection leads to an increase in the rate of transmission and in the number of new cases among children, who may also be more likely to be diagnosed with long-term physical impairments.

 

I urge States and other stakeholders, including the health industry, to ensure child-friendly, gender-sensitive, disability-inclusive services, including health and child protection, as well as appropriate medical expertise and public policies to treat leprosy in children. Children affected by leprosy must be recognized as rights-holders and their meaningful participation in relevant policy-making processes must be duly enabled."

 

ENDS

 

This statement was endorsed by the Committee on the Rights of the Child (CRC) and the United Nations Children's Fund (UNICEF).

Ms Alice Cruz is the UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members. She was appointed in November 2017 by the Human Rights Council. Ms. Cruz worked as External Professor at the Law School of University Andina Simón Bolívar – Ecuador and in several Portuguese universities as researcher on health and human rights, in particular leprosy. She participated in the elaboration of WHO Guidelines for Strengthening Participation of Persons Affected by Leprosy in Leprosy Services. She has researched and written on the subject of eliminating leprosy and the stigma attached to it and has interacted with various stakeholders, including persons affected by leprosy.

The Special Rapporteurs are part of what is known as the Special Procedures of the Human Rights Council. Special Procedures, the largest body of independent experts in the UN Human Rights system, is the general name of the Council's independent fact-finding and monitoring mechanisms that address either specific country situations or thematic issues in all parts of the world. Special Procedures experts work on a voluntary basis; they are not UN staff and do not receive a salary for their work. They are independent from any government or organization and serve in their individual capacity.

For inquiries and media requests, please contact: Ms. Younkyo Ahn ( + 41 22 917 9537 / younkyo.ahn@un.org)

For media inquiries related to other UN independent experts please contact
: Maya Derouaz (maya.derouaz@un.org) or Dharisha Indraguptha (dharisha.indraguptha@un.org)

Follow the UN's independent human rights experts on Twitter @UN_SPExperts

Concerned about the world we live in?
Then STAND UP for someone's rights today.
#Standup4humanrights
and visit the web page at 
http://www.standup4humanrights.org

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/3ecd777a-8d0e-44d9-ad54-d47127edbfc8n%40googlegroups.com.


From: Leprosy Mailing List <leprosymailinglist@googlegroups.com>
Sent: 29 January 2023 17:48
To: Leprosy Mailing List <leprosymailinglist@googlegroups.com>
Subject: Ref.: (LML) Children affected by leprosy remain invisible, forgotten, and dehumanised
 

 

 

 
Leprosy Mailing List – January 29 ,  2023

 

Ref.:  (LML) Children affected by leprosy remain invisible, forgotten, and dehumanised

From:  Alice Cruz, Quito, Ecuador

 

 

Dear Colleagues,

 

Kindly find herewith my last public statement as SR on World Leprosy Day.

As you can see, this statement was endorsed by the Committee on the Rights of the Child and the UNICEF, a great sign of progress with regard to the mainstreaming of Hansen's disease in the overall UN system.

 

Kind regards,

Alice

 

Note Editor: On January 29, 2023, the last Sunday of January, we ask special attention for a World Free of Leprosy, and we call it the World Leprosy Day

 

Children affected by leprosy remain invisible, forgotten, and dehumanised: UN expert

GENEVA (26 January 2023) Children and teenagers affected by leprosy (also known as Hansen's disease) remain hidden, invisible, forgotten and dehumanised, a UN expert said today. Ahead of World Leprosy Day, the Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members, Alice Cruz, issued the following statement:

 

"Leprosy is mostly diagnosed in children aged between 10 and 14 years due to its long incubation period following exposure. Cases among younger children have been observed and, more rarely, cases in infants have also been reported.

 

Since the creation of my mandate in 2017, I have received numerous reports of children affected by leprosy being expelled from schools, separated from other students, rejected by their peers, bullied, verbally and physically abused by family members, neighbours, and schoolteachers. Due to a lack of access to medical care and stigmatisation, informal segregation in "leprosy colonies" still happens in some cases, even if it is no longer implemented as State policy.

 

I received considerable testimonies about persons diagnosed with leprosy during their childhood and who attempted to commit suicide as adults. Stigmatisation has long-lasting impacts over an entire lifetime. Girls affected by leprosy are especially vulnerable to various forms of discrimination and violence.

 

Detection of leprosy cases was significantly impacted by the Covid-19 pandemic when the global detection rate for new child cases dropped from 7.9 to 4.5 per million child population. This is alarming because children affected by leprosy are a strong indicator of the extent of ongoing transmission. For leprosy, under-detection leads to an increase in the rate of transmission and in the number of new cases among children, who may also be more likely to be diagnosed with long-term physical impairments.

 

I urge States and other stakeholders, including the health industry, to ensure child-friendly, gender-sensitive, disability-inclusive services, including health and child protection, as well as appropriate medical expertise and public policies to treat leprosy in children. Children affected by leprosy must be recognized as rights-holders and their meaningful participation in relevant policy-making processes must be duly enabled."

 

ENDS

 

This statement was endorsed by the Committee on the Rights of the Child (CRC) and the United Nations Children's Fund (UNICEF).

Ms Alice Cruz is the UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members. She was appointed in November 2017 by the Human Rights Council. Ms. Cruz worked as External Professor at the Law School of University Andina Simón Bolívar – Ecuador and in several Portuguese universities as researcher on health and human rights, in particular leprosy. She participated in the elaboration of WHO Guidelines for Strengthening Participation of Persons Affected by Leprosy in Leprosy Services. She has researched and written on the subject of eliminating leprosy and the stigma attached to it and has interacted with various stakeholders, including persons affected by leprosy.

The Special Rapporteurs are part of what is known as the Special Procedures of the Human Rights Council. Special Procedures, the largest body of independent experts in the UN Human Rights system, is the general name of the Council's independent fact-finding and monitoring mechanisms that address either specific country situations or thematic issues in all parts of the world. Special Procedures experts work on a voluntary basis; they are not UN staff and do not receive a salary for their work. They are independent from any government or organization and serve in their individual capacity.

For inquiries and media requests, please contact: Ms. Younkyo Ahn ( + 41 22 917 9537 / younkyo.ahn@un.org)

For media inquiries related to other UN independent experts please contact
: Maya Derouaz (maya.derouaz@un.org) or Dharisha Indraguptha (dharisha.indraguptha@un.org)

Follow the UN's independent human rights experts on Twitter @UN_SPExperts

Concerned about the world we live in?
Then STAND UP for someone's rights today.
#Standup4humanrights
and visit the web page at 
http://www.standup4humanrights.org

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/3ecd777a-8d0e-44d9-ad54-d47127edbfc8n%40googlegroups.com.

Fw: Ref.: (LML) Virtual Photo Exhibition on leprosy in Indonesia

 

 
Leprosy Mailing List – January 29,  2023

 

Ref.:  (LML) Virtual Photo Exhibition on leprosy in Indonesia

 

From:  Laila de Laguiche, Curitiba, Brazil

 

Dear Pieter,

I really appreciate this photo essay posted last 24th.


Congratulations Yoppy Pieter for the excellent quality photos and, above all, for the wonderful accompanying text. 

 

Resilience, pragmatism and a lot of faith can help a lot populations that still suffer from isolation, prejudice and restricted access to health treatments.


It is always good to give visibility to this problem, which for us can be seen as a repetition, but thousands/millions of people still doubt the existence of Hansen's Disease.


I will disclose as much as I can.


Best Regards

 

Laila de Laguiche

Curitiba - Brazil

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/facf7fcc-d185-4532-80ba-18a818cb4de6n%40googlegroups.com.


From: Leprosy Mailing List <leprosymailinglist@googlegroups.com>
Sent: 29 January 2023 17:52
To: Leprosy Mailing List <leprosymailinglist@googlegroups.com>
Subject: Ref.: (LML) Virtual Photo Exhibition on leprosy in Indonesia
 

 
Leprosy Mailing List – January 29,  2023

 

Ref.:  (LML) Virtual Photo Exhibition on leprosy in Indonesia

 

From:  Laila de Laguiche, Curitiba, Brazil

 

Dear Pieter,

I really appreciate this photo essay posted last 24th.


Congratulations Yoppy Pieter for the excellent quality photos and, above all, for the wonderful accompanying text. 

 

Resilience, pragmatism and a lot of faith can help a lot populations that still suffer from isolation, prejudice and restricted access to health treatments.


It is always good to give visibility to this problem, which for us can be seen as a repetition, but thousands/millions of people still doubt the existence of Hansen's Disease.


I will disclose as much as I can.


Best Regards

 

Laila de Laguiche

Curitiba - Brazil

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/facf7fcc-d185-4532-80ba-18a818cb4de6n%40googlegroups.com.

Fw: Ref.: (LML) Message from Pope Francis

 


Leprosy Mailing List – January 29,  2023

 

Ref.:  (LML) Message from Pope Francis

From:  Laila de Laguiche, Curitiba, Brazil

 

Dear Pieter,


This week I had the opportunity to participate in the second Vatican Leprosy Symposium, organized by AIFO, Raoul Follerau, Sasakawa and Dicastery for Promoting Integral Human.

We received this beautiful message from the Pope, who talks a lot about World Leprosy Day and encourages a reflective spirit on what we can do to fight stigma and prejudice.

Furthermore, His blessings must reach everyone: patients, professionals and managers.
If you find it convenient, please post it on the LML list.

 

https://www.vatican.va/content/francesco/en/events/event.dir.html/content/vaticanevents/en/2023/1/23/messaggio-simposio-malattia-hansen.html


(I am not a Christian myself, but I felt very grateful for your blessings)

Thanks

 

Laila

 

Laila de Laguiche

Curitiba - Brazil

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/8c6bd983-8131-40bd-a3de-b14f0d39c833n%40googlegroups.com.

Saturday, January 28, 2023

Fw: Ref.: (LML) Photo exhibition from Indonesia


 

 

Leprosy Mailing List – January 28,  2023

 

Ref.:  (LML) Photo exhibition from Indonesia

 

From:  Robert Machangu, Tanzania

 

Dear Pieter,

 

This narrative from indonesia  is very very  and it repeats  itself in many remote communities in leprosy endemic countries. Let us hope that with more vigorous campaigns and interventions. HD will become history in the next couple of decades.  Thank you Yoppy.

 

Robert Machangu

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/be33f57d-4822-407a-9124-baddd303cdd4n%40googlegroups.com.


From: Leprosy Mailing List <leprosymailinglist@googlegroups.com>
Sent: 28 January 2023 16:43
To: Leprosy Mailing List <leprosymailinglist@googlegroups.com>
Subject: Ref.: (LML) Photo exhibition from Indonesia
 

 

Leprosy Mailing List – January 28,  2023

 

Ref.:  (LML) Photo exhibition from Indonesia

 

From:  Robert Machangu, Tanzania

 

Dear Pieter,

 

This narrative from indonesia  is very very  and it repeats  itself in many remote communities in leprosy endemic countries. Let us hope that with more vigorous campaigns and interventions. HD will become history in the next couple of decades.  Thank you Yoppy.

 

Robert Machangu

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/be33f57d-4822-407a-9124-baddd303cdd4n%40googlegroups.com.

Fw: Ref.: (LML) Teledermatology services

 

Leprosy Mailing List – Jamuary 28,  2023

 

Ref.:  (LML) Teledermatology services

From:  Joel Almeida, Mumbai, India

 

Dear Pieter and colleagues,

It is very heartening to see the spread of teledermatology services using smartphones. (eg in Indonesia, ref LML Virtual Photo Exhibition). This allows peripheral health workers to be supervised by experts as they examine patients with skin conditions. Without expertise, it is easy for the most highly bacillated HD patients to be missed, either before MDT or after MDT upon reinfection. That is because the most highly bacillated often show no skin patches.

With improved standards of skin examination, including pinching the skin to check for subtle induration, there is hope that the most highly bacillated patients will be recognised, treated and consequently unable to provide viable bacilli to children and others. Programmes that provide smear microscopy might find nasal smears thick with acid-fast bacilli even though the patient might not show any skin patches. While such patients remain unprotected against (re)infection, there is not much hope of stopping transmission. 

A wider reach for expert services is critical for stopping HD transmission and caring for patients. Teledermatology & telemedicine of all sorts can help.

Best,

Joel Almeida

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/c763b0a7-6c0e-4a0b-af7d-c5ffb0ffbfcan%40googlegroups.com.

Wednesday, January 25, 2023

Fw: (LML) Virtual Photo Exhibition on leprosy in Indonesia


 
Leprosy Mailing List – January 24,  2023

 

Ref.: (LML) Virtual Photo Exhibition on leprosy in Indonesia

 

From:  Marlous Grijsen, OUCRU Indonesia

 

 

Dear Pieter and colleagues,

 

 

On behalf of Oxford University Clinical Research Unit Indonesia, I am excited to announce our online photo exhibition entitled 'Letter from the Hills: the Invisible Burden of Leprosy in Sumba' by Yoppy Pieter, an award-winning Indonesian photographer. The exhibition documents, through a series of intimate and subtle images, the invisible burden of leprosy in Sumba, a remote island in Eastern Indonesia. 

 

In this exhibition Yoppy Pieter shares a glimpse of the lives of seven people affected by leprosy from Sumba, exposing their daily challenges, but at the same time illustrating their resilience, vigour and hopes for the future. Through these personal stories, we aim to raise awareness and improve the public knowledge on leprosy to help destigmatise this neglected disease. 

 

Please visit the virtual exhibition at: https://www.invisibleburdenofleprosy.com and share among your colleagues, patients, friends and/or family. 

 

 

Best wishes,

 

 

Marlous Grijsen, MD PhD
Dermatologist & Research Fellow

Centre for Tropical Medicine and Global Health
Nuffield Department of Medicine
University of Oxford

Oxford University Clinical Research Unit Indonesia
Fakultas Kedokteran Universitas Indonesia
Jakarta Indonesia


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/cf99204e-736c-43e5-81d1-64e0deb428cfn%40googlegroups.com.

Sunday, January 22, 2023

Fw: Ref.: (LML) Leprosy Research Initiative calls for Proposals


 

 

Leprosy Mailing List – January 22,  2023

 

Ref.:  (LML) Leprosy Research Initiative calls for Proposals

 

From:  LRI, Amsterdam, the Netherlands

 

 

Dear colleagues,

 

 



LRI calls for proposals: deadline for Letter of Intent submission 27/01/2023

The countdown has started!
There is only one week left to submit your Letter of Intent for the following LRI Calls for proposals:
- Regular grant – Projects starting in 2024
- Research capacity strengthening grant – Projects starting in 2023
 
The deadline for submission for both calls is Friday the 27th of January, 2023 at 23:59 (CET), after which the portal will be closed, so make sure to submit your Letter of Intent

 


 




LRI Spring Meeting 2023 & Highlights – Save the date!

The LRI Spring Meeting is an annual event that brings together researchers of LRI-funded projects,  the LRI Scientific Review Committee and Steering Committee as well as Partners of the LRI. More than thirty researchers will present project progress updates and results during this year's edition, which will take place in the Netherlands on the 20th and 21st of April. Limited places are available for self-funded persons with a keen interest in leprosy research who wish to attend but are not otherwise invited.

Following the in-person event, an online 'Highlights of Spring Meeting 2023' event will be hosted on the 1st of June , where findings of selected projects across LRI research priorities will be presented. This event is open to everyone interested in leprosy research and will be free of charge.

Updates on these events will follow via newsletter communication on our website in due course.

 

Best regards,


LRI team

 



New publication: "Meaningful engagement of persons affected by leprosy in research: an exploration of its interpretation, barriers, and opportunities"

We are pleased to share the scientific article led by LRI intern Laura de Groot recently published in Tropical Medicine and Infectious Disease on her project on meaningful engagement of persons affected by leprosy in research.

The authors recommend to "engage experts-by-experience throughout the entire research cycle for optimal outcomes and impact for all stakeholders involved, although the process of engagement can vary across research stages. Funders can play an important role in both stimulating engagement, for example, by accepting that payment of experts-by-experience is a legitimate use of funds, and in recognizing differences between meaningful and tokenistic engagement."
 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/a6da7296-776c-45f3-a8fe-3326c5586db4n%40googlegroups.com.

Wednesday, January 18, 2023

Fw: Ref.: (LML) Request for Leprosy Training

 

Leprosy Mailing List – January 18,  2023

 

Ref.:  (LML) Request for Leprosy Training

 

From:  Joel Almeida, Mumbai, India

 

 

Dear Pieter & colleagues,

Schieffelin Institute, Karigiri (India) has long offered good courses on HD. These courses tended to attract participants from around the globe. Good idea for such institutes of excellence to be sponsored for providing hands-on training to health personnel.

With good training of health personnel there will be less risk that highly bacillated patients before or after MDT, often showing only subtle physical signs, will be overlooked. Then we can match the achievements of the best control programmes (including Karigiri) that demonstrated well documented and large reductions in the incidence rate of multibacillary HD.

Best wishes to the younger professionals joining the (winnable) battle to defeat the germs and improve respect/services for those affected. And to all other esteemed colleagues and friends too.

Joel Almeida


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/3ecea043-7456-4e7c-b6d2-a138068f5b01n%40googlegroups.com.

Sunday, January 15, 2023

Fw: Ref.:  (LML) Request for Leprosy Training

 

 


Leprosy Mailing List – January 15,  2023

 

Ref.:  (LML) Request for Leprosy Training

 

 

From:  Francesca Gajete, Manilla, Philippines

 

Dear Pieter,

 

Greetings for a better year this 2023 for your family and all of us !

 

I am sharing this letter request from Dr Ricky Hipolito, a dedicated Dermatologist and Leprosy worker at the Research Institute on Tropical Medicine Philippines.

 

It is very rare that such young dermatologist would come forward showing interest in a field chosen by few.

 

With high hopes of your assistance cognizant of your large network.

 

Best Wishes and Kind Regards to the Family. Take care and Stay safe always.

 

Yours in Leprosy Service,

 

 

Francesca 

 

 

Dr. Francesca Cando Gajete, MHA, FPLS

Former National Leprosy Control Program Manager-DOH (Ret)

ADOHRE Philippines, Inc Chair and Board of Trustee

International Leprosy Association Vice President for Asia

Representative WHO Western Pacific Regional Committee

 

Dear Dr Gajete,

 

I am Dr Ricky H. Hipolito, a consultant at the Research Institute for Tropical Medicine. Since 2012 I have have been seeing Leprosy patients and have actively participated in many Leprosy programs of the Department of Health. Among these programs are the Leprosy E- learning module, in which I am a contributor, trainings for the Department of Health and researches concerning Leprosy diagnosis and management. I also initiated the Leprosy Livelihood Training in RITM.

 

In relation to this, I would like to request for a short training course, preferably sponsored by the World Health Organization (WHO) on Leprosy so I can update myself on the current trends on this condition. I hope to gain new skills through courses of 2 to 3 months, which can be scheduled in 2024. This training will enhance the services I provide to RITM Leprosy patients especially the indigents. We are also implementing researches on Leprosy and with this training our research outputs will be enhanced.

 

I am look forward to hearing from you soon.

 

Thank you for considering my request.

 

Ricky Hipolito, MD

Medical Specialist II

Department of Dermatology

Research Institute for Tropical Medicine – Department of Health       

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/2577728b-45bd-475d-8fbf-62630a52654en%40googlegroups.com.

Wednesday, January 11, 2023

Fw: Ref.:  (LML) Infolep monthly overview of new publications on leprosy, January 2023

 


Leprosy Mailing List – January 11,  2023

 

Ref.:  (LML) Infolep monthly overview of new publications on leprosy, January 2023

From:  Roos Geutjes and Marente Mol, Amsterdam, the Netherlands

 

 




Dear colleagues, 

First of all, we would like to wish you all the best for 2023! We are looking forward to a new year full of achievements and successes in our work towards a world without leprosy.

We have exciting developments planned for this year! Infolep is currently in the process of developing a separate search functionality for practical materials on the portal where national programme managers, NGO programme staff, trainers, health institutions and health professionals can easily access practical leprosy resources, such as training materials, guidelines, manuals, online courses, and more. This functionality will be implemented in Q1 2023. 

A new Leprosy Review issue is now available!

World Leprosy Day 2023 takes place on the 29th of January!

Reminder! The deadline for Leprosy Research Initiative's calls for proposals is January 27th, 2023 at 23:59 (CET). Do not forget to submit your application timely!

Enjoy reading the latest publications that are listed below. Feel free to contact us to receive the full-text versions when these cannot be found on Infolep. We would also be happy to assist you with literature searches. 

Warm regards,

Roos Geutjes & Marente Mol

www.leprosy-information.org
info@infolep.org
 

 



 



Highlighted

 



Gender and health: awareness, analysis, and action - 2022 (online course)
Pan American Health Organization. 2022.
 

Towards Disability Inclusive Sexual And Reproductive Health & Rights  
Dutch Coalition on Disability and Development. 2022.
 

Global report on health equity for persons with disabilities  
World Health Organization. 2022.
 

Disability-Inclusive Health Care Systems : Technical Note for World Bank Task Teams  
World Bank. 2022.
 

 



 



New publications


Feel free to contact us to receive full-text versions if these cannot be found through the Infolep portal.

 



Stigma towards leprosy across seven life domains in Indonesia: a qualitative systematic review.  
Marpaung Y, Ernawati E, Dwivania A. BMJ open. 2022; 12 (11) : e062372.
 

Health workers' perceptions of leprosy and factors influencing their perceptions in endemic countries: A systematic literature review  
Haverkort E, van 't Noordende AT. Leprosy Review. Lepra. 2022; 93 (4) : 332-347.
 

Assessing independence in activities of individuals affected by leprosy  
Bhat L, Khan N, Vaida N, et al. Leprosy Review. Lepra. 2022; 93 (4) : 392-407.
 

The Attitude of People Affected with Leprosy towards Fellow People Affected with Leprosy in an Endemic District, West Bengal, India
Pitchaimani G, Srinivasan S, Darlong J. Indian Journal of Leprosy. 2022.
 

What factors influence adherence and non-adherence to multi-drug therapy for the treatment of leprosy within the World Health Organisation South East Asia region? A systematic review
Meadows T, Davey G. Leprosy Review. Lepra. 2022; 93 (4) : 311-331.
 

Utility of a Mycobacterium leprae molecular viability assay for clinical leprosy: An analysis of cases from the Philippines, Ethiopia, and Nepal  
Lenz SM, Ray NA, Lema T, et al. Frontiers in Tropical Diseases. Frontiers Media SA. 2022.
 

Molecular detection of drug resistance in clinical specimens of leprosy patients from a tertiary care leprosy centre in South India
Muthusamy S, Vilvanathan SA, Dhandapany SP, et al. Leprosy Review. Lepra. 2022; 93 (4) : 370-376.
 

The Role of Interleukin-10 in Leprosy: A Review
Oktariana D, Saleh I, Hafy Z, et al. Indian Journal of Leprosy. 2022.
 

Leptin Deficiency May Influence the Divergence of Cell-Mediated Immunity Between Lepromatous and Tuberculoid Leprosy Patients.  
Degechisa S, Dabi Y. Journal of inflammation research. 2022.
 

Strongyloidiasis infection in a borderline lepromatous leprosy patient with adrenocorticoid insufficiency undergoing corticosteroid treatment: a case report.  
Morel R, Maddumabandara K, Amarasinghe N, et al. Journal of medical case reports. 2022; 16 (1) : 458.
 

Milia Over Healing Leprosy Plaque: A Rare Presentation
Sharmeen A, Varshney I, Adil M, et al. Indian Journal of Leprosy. 2022;
 

Study of Correlation of High-Resolution Ultrasonography and Ultrasonography Guided Fine Needle Aspiration Cytology in Diagnosis of Pure Neuritic Leprosy in a Tertiary Care Hospital  
Jena S, Panda S, Mohanty P, et al. Indian Journal of Leprosy. 2022;
 

A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale.  
Saxena S, Arora P, Sardana K, et al. Indian journal of dermatology. 2022; 67 (4) : 425-427.
 

The use of imagery in global health: an analysis of infectious disease documents and a framework to guide practice
Charani E, Shariq S, Cardoso Pinto AM, et al. The Lancet Global Health. Elsevier BV. 2023; 11 (1) : e155-e164.
 

Self-care interventions and practices as essential approaches to strengthening health-care delivery  
Narasimhan M, Aujla M, Van Lerberghe W. The Lancet Global Health. Elsevier BV. 2023; 11 (1) : e21-e22.
 

Global Financing for Health Policy and Systems Research: A Review of Funding Opportunities
Kentikelenis A, Ghaffar A, McKee M, et al. Health Policy and Planning. Oxford University Press (OUP). 2022.
 

 


Assessing the Quality of the World Health Organization's Skin NTDs App as a Training Tool in Ghana and Kenya: Protocol for a Cross-sectional Study.  
Frej A, Cano M, Ruiz-Postigo J, et al. JMIR research protocols. 2022; 11 (12) : e39393.
 

Identifying clusters of leprosy patients in India: A comparison of methods  
Taal AT, Garg A, Lisam S, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2022; 16 (12) : e0010972.
 

Spatial distribution and epidemiological profile of leprosy cases in Brazil between 2012 and 2021 Andrade SMD, Andrade MVMD, Silva LAD, et al. International Journal of Advanced Engineering Research and Science. AI Publications. 2022; 9 (11) : 256-262.
 

Rising percentage of new female leprosy cases since 2004
Quilter EEV, Lockwood DNJ, Ruth Butlin C. Leprosy Review. Lepra. 2022; 93 (4) : 364-369.
 

Improving early case detection in leprosy: Reports from recent workshops
Saunderson P. Leprosy Review. Lepra. 2022; 93 (4) : 292-297.
 

Short report for Leprosy Review: ILEP Conference, 2022: Active case-finding
Warne G, Mukhier M. Leprosy Review. Lepra. 2022; 93 (4) : 424-430.
 

Leprosy in Europe – towards zero leprosy  
Saunderson P, Fastenau A. Leprosy Review. Lepra. 2022; 93 (4) : 298-310.
 

Leprosy in posteradication era – A clinicopathological correlation: How far we have achieved?
Deepti Gangwar , Amitosh Mishra , Sara Siddiqui , et al. Asian Journal of Medical Sciences. Nepal Journals Online (JOL). 2022; 13 (12) : 144-148.
 

Use of multi-criteria methods to support decision-making in drug management for leprosy patients
Falcão IW, Souza DS, Cardoso DL, et al. International Journal of Management and Decision Making. Inderscience Publishers. 2023; 22 (1) : 53.
 

Objective Structured Clinical Examination as a Training Tool for Leprosy in the Time of Elimination.  
Bhardwaj A, Beniwal R. Indian journal of dermatology. 2022; 67 (4) : 480.
 

Corroboration of cross-reactivity between and hosts' salivary and cutaneous proteins: A hope for prognostic biomarkers for the pathogenesis of reactions in leprosy.
Pathak V, Singh I, Singh S, et al. Frontiers in microbiology. 2022.
 

A masquerade: An uncommon presentation of a dual infection of leprosy and human immunodeficiency virus
Bhatt V, Zanwar A, Patel A, et al. International Journal of Mycobacteriology. Medknow. 2022; 11 (4) : 457.
 

Changes in Plasma Level of Endocrine Hormones in Lepromatous Leprosy Patients  
Dabi YT, Degechisa ST, Bobosha K, et al. IJID Regions. Elsevier BV. 2022.
 

Sensory Ganglionopathy in Hansen's Disease: Report of a Patient and Review of Literature
Chaudhary S, Kalita J, Misra U. Indian Journal of Leprosy. 2022.
 

Facial nerve and branch dysfunction in leprosy - a study from India  
Philip AS, George A, Mathew V, et al. Leprosy Review. Lepra. 2022; 93 (4) : 377-391.
 

Enfermedad de Hansen en Colombia, 2022: perspectiva epidemiológica  
Serna-Trejos JS, Bermúdez-Moyano SG. Metro Ciencia. 2022; 30 (4) : 94-97.
 

O processo de trabalho na Atenção Primária à Saúde e o controle da hanseníase: revisão integrativa
Menezes MS, Costa RM, Monteiro LD, et al. Research, Society and Development. Research, Society and Development. 2023; 12 (1) : e1012139203.

 

 



 



News & Events

 



World Leprosy Day
29 January, 2023

World Leprosy Day is a celebration of the leprosy community and an opportunity to raise public awareness of the disease. The theme of World Leprosy Day 2023 is "Act Now. End Leprosy." Help increasing awareness by spreading the message using the social media toolkit developed by Global Partnership for Zero Leprosy and ILEP. Or visit our Infolep page on World Leprosy Day - more information and resources will be added later on!
 

International Symposium at the Vatican on Hansen's Disease "Leave No One Behind" & GLOBAL APPEAL 2023 to End Stigma and Discrimination against Persons Affected by Leprosy
23 & 24 January, 2023

This symposium aims to examine the progress made against leprosy over the past six and a half years and the challenges that remain, and provide stakeholders with an opportunity to discuss future actions to realize a world free from leprosy and its associated problems. In addition, the symposium will also incorporate the launch ceremony for Global Appeal 2023 to End Stigma and Discrimination against Persons Affected by Leprosy. Register now for either virtual or physical attendance!
 

The Mwele Malecela Mentorship Programme for Women in Neglected Tropical Diseases 

The Mwele Malecela Mentorship (MMM) Program for Women in Neglected Tropical Diseases supports mid-career African women to become leaders and champions in NTD elimination at national and international levels. The MMM program will provide mentorship, training and networking opportunities over two years to cohorts of women from 2023 to 2030. The deadline for application is 15 January, 2023. 
 

COR-NTD Research Link sessions

  • 8 February, 2023: Maximizing the untapped potential of NTD platforms to reach marginalized communities during future global health crises
  • 22 February, 2023: Achieving the WHO 2030 NTD Roadmap goals: systems and data-driven approaches to improve program strategy, planning and implementation for the elimination of PC-NTDs

The 5th Asia-Pacific Community-Based Inclusive Development Congress
15-17 March, 2023

The 5th AP-CBID Congress will take place in Phnom Penh, Cambodia. The content of the congress focuses on strengthening social and economic empowerment of persons with disabilities during and after the COVID-19 pandemic through community-based inclusive development.
 

 


Leprosy Review - New issue

Leprosy Review published a new issue in December, 2022. All articles are freely accessible via the website.
 

Calls for proposals - Leprosy Research Initiative

This year, LRI has announced two calls for proposals! This includes the regular annual call for proposals, for funding commencing in 2024. LRI funds research with a focus on leprosy – including research applications combining leprosy with other neglected tropical diseases (NTDs) or other diseases that share cross-cutting issues with leprosy. Alongside the regular call, LRI has now introduced a new Research capacity strengthening grant, for funding commencing in 2023. Letters of Intent can now be submitted via the LRI application portal. The deadline for submission for both calls is January 27th, 2023. Interested? More information can be found on their website!
 

Africa Health Agenda International Conference 2023
5-8 March, 2023

Amref Health Africa, together with partners, is hosting the Africa Health Agenda International Conference (AHAIC) in Rwanda. The focus of the conference is building resilient health systems for Africa to effectively respond to future pandemics and address long-standing health challenges affecting the people of the African continent.
 

Global Health Equity Dialogue Series: How Can Health Equity Accelerate Progress toward Universal Health Coverage in Global Settings?

On December 13, 2022, RTI International hosted its first virtual session in a Global Health Equity Dialogue Series. This first session focused on the current state of health equity worldwide, major gaps in investments, and how prioritizing health equity can help countries to advance universal healthcare. The video recording of the session is available on YouTube.
 

Global Health Compassion Rounds - Three Years in Synthesis: Connecting the Dots & Charting a Way Forward 

In the last GHCR session, three years of compassion rounds were wrapped together. In case you missed it, the video of the session can be found via the link above. 

 

 



 



Links

 



Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 

ALLF - Official website of the Association des Léprologues de Langue Française
 

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

 


ILEP newsletter archive

GPZL newsletter subscription

WHO Goodwill Ambassador's Leprosy Bulletin

Leprosy Review

Leprosy Review Repository (1928-2001)

Fontilles Revista de Leprología

Indian Journal of Leprosy

Hansenologia Internationalis

 




GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 


 



LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/49ca2702-e492-4cc9-a6f0-0f054c9e522cn%40googlegroups.com.